Mizokami, Masashi

Publishing since 1984 (Dinosaur)

Has published 341 publications in 27 years

Number of publications published per year by Mizokami, Masashi. (Source : PubMed)

Distribution of publications types for Mizokami, Masashi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Panduro A, Roman S, Khan A, Tanaka Y, Kurbanov F, Martinez-Lopez E, Campollo O, Hernandez-Nazara Z, Mizokami M. Molecular epidemiology of hepatitis C virus genotypes in West Mexico.  Virus Res.  2010  
•  Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y. Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand.  J. Med. Virol.  2010;82;2  
•  Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus.  Hepatol. Res.  2010;40;1  
•  Yano K, Tamada Y, Yatsuhashi H, Komori A, Abiru S, Ito K, Masaki N, Mizokami M, Ishibashi H. Dynamic epidemiology of acute viral hepatitis in Japan.  Intervirology  2010;53;1  
•  Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.  Nat. Genet.  2009;41;10  
•  Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J.  J. Virol.  2009;83;20  
•  Aly HH, Qi Y, Atsuzawa K, Usuda N, Takada Y, Mizokami M, Shimotohno K, Hijikata M. Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.  Hepatology  2009;50;3  
•  Fung J, Lai CL, Tanaka Y, Mizokami M, Yuen J, Wong DK, Yuen MF. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.  Am. J. Gastroenterol.  2009;104;8  
•  Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, Yanaga K, Monden M, Kiyosawa K. Donor complications associated with living donor liver transplantation in Japan.  Transplantation  2009;88;1  
•  Kusakabe A, Tanaka Y, Mochida S, Nakayama N, Inoue K, Sata M, Isoda N, Kang JH, Sumino Y, Yatsuhashi H, Takikawa Y, Kaneko S, Yamada G, Karino Y, Tanaka E, Kato J, Sakaida I, Izumi N, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M. Case-control study for the identification of virological factors associated with fulminant hepatitis B.  Hepatol. Res.  2009;39;7  

[ See timeline ] [ See all publications ]